没有足够的证据确定心血管衰竭婴儿是否得益于容积扩张。
There is insufficient evidence to determine whether infants with cardiovascular compromise benefit from volume expansion.
然而，却鲜有研究能够探明焦虑在预测心血管疾病中作用，这些病包括心脏病突发、中风、甚至心脏衰竭和死亡。
Yet few studies have looked into the role of anxiety in predicting cardiovascular problems like heart attacks, strokes and even heart failure and death.
本次有关心血管健康的研究共有5338人参与，他们都没有普遍性的心脏衰竭疾病。
The Cardiovascular Health Study involved 5, 338 participants with no prevalent heart failure.
《国际循环》：再生治疗为心血管疾病包括心力衰竭患者提供了一个有前景的治疗方法。
International Circulation: Regenerative medicine represents a promising perspective on therapeutic angiogenesis in patients with cardiovascular disease, including heart failure.
社会经济地位较低的患者有更多的动脉粥样硬化，严重的心血管疾病，心脏病发作先兆，左心功能不全，心力衰竭。
Patients in lower socioeconomic positions had more atherosclerosis, serious cardiovascular disease, prior heart attacks, left ventricular dysfunction and heart failure.
《心血管护理杂志》提出，可以使用C0 - Q 10来治疗和预防各种心血管疾病如心脏衰竭，高脂血症，冠心病，高血压。
As per the Journal of cardiovascular Nursing, you can use C0-Q10 to treat and prevent various cardiovascular diseases like heart failure, hyperlipidemia, coronary heart disease, and hypertension.
目的：探讨应用血管紧张素转化酶抑制剂(acei)治疗心血管疾病时引起急性肾衰竭和高钾血症的原因及其应对方法。
OBJECTIVE: To study the reasons for acute renal failure (ARF) and hyperkalemia caused by ACEI which is used for treating cardiovascular disease, and the dealing method.
慢性心力衰竭(C HF)是常见的心血管疾病之一。
Chronic heart failure (CHF) is a common one of cardiovascular disease.
平均随访8.2年，共有554名参与者出现致死性和非致死性心血管事件，包括心肌梗死、卒中、冠心病和心力衰竭。
Over an average of 8.2 years of follow-up, 554 participants experienced fatal and nonfatal cardiovascular events, including myocardial infarction, stroke, coronary artery disease, and heart failure.
综述脑钠素在小儿心血管疾病中的研究成果和现状，总结BNP对小儿心力衰竭诊断的参考价值。
To summarize the position and status of BNP s study in pediatric cardiovascular disease and its value of referring to diagnose the heart failure in childhood.
患者前瞻性的随访了平均655天，主要终点是心血管死亡和因心力衰竭加重而住院。
Patients were prospectively followed during a median follow-up period of 655 days with the end points of cardiac death or progressive heart failure requiring rehospitalization.
此外，无糖耐量异常的肥胖与心血管疾病相关，包括冠心病、中风、心力衰竭。
Moreover, obesity in the absence of glucose intolerance is associated with CVD, including coronary heart disease, stroke, and heart failure.
同时，消化道溃疡、感染、心血管系统衰竭等相关并发症的发生并不显著增加。
And complications such as digestive ulcer, infection, cardiovascular system failure related to mp are.
血管紧张素转换酶抑制剂是治疗心血管疾病，特别是高血压和心力衰竭的重要药物。
Angiotensin - Converting enzyme inhibitors are important drugs for cardiovascular diseases, especially hypertension and heart failure.
高uacr与高风险死于心血管病因或入院时心力衰竭恶化相关。
Higher UACR was linked with increased risk of death from cardiovascular causes or admission to hospital with deteriorating heart failure.
前言心力衰竭作为一种慢性疾病，是大多数心血管疾病最主要的死亡原因。
ForewordAs a chronic disease, heart failure is the major cause of death in majority of cardiovascular diseases.
血管紧张素ii在心血管并发症(如心肌梗死、心力衰竭)的进展中起到关键作用。
Angiotensin II is critical in both the evolution of cardiovascular complications such as myocardial infarction and eventually heart failure.
少量的内毒素就能引起脓毒血症和败血性的休克，从而导致高血压，心血管衰弱，多器官衰竭甚至死亡。
Serious endotoxin intoxication can cause sepsis and septic shocks, leading to severe hypertension, cardiovascular collapse, multiple organ failure and death.
因此，慢性充血性心力衰竭的发病机制和治疗一直是心血管领域研究的重点之一。
So the pathogenesis and therapy of CHF are a focal point of cardiovascular diseases.
心力衰竭是一种严重的疾病，5年存活率与恶性肿瘤相仿，正成为21世纪最重要的心血管疾病。
Heart failure is a serious disease. It is the most important cardiovascular disease of the 21st century, whose 5-year survival rate is similar to malignant tumors.
心力衰竭(心衰)是由多种心血管疾病引起的心功能不全，最终出现心肌局部坏死和不可逆转的纤维化。
Heart failure (CHF) is the direct cause of death of a variety of cardiovascular diseases, culminating in irreversible myocardial necrosis and fibrosis.
巨量白蛋白尿的患者组，其肾病进展的危险因素与微量白蛋白尿组相似，其进展的患者肾小球滤过率较低（GFRs）且诊断有心血管疾病或心力衰竭。
The macroalbuminuria group had risk factors similar to the microalbuminuria group, and had lower glomerular filtration rates (GFRs) and a diagnosis of cardiovascular disease or heart failure.
结果各器官衰竭的发生率依次为肺、心血管、脑、肾、肝、胃肠、血液。
Results The morbidity of organ failure was in order of respiratory, cardiac, cerebral, renal, liver, gastrointestinal and blood.
炎症与心力衰竭的关系是心血管领域的研究热点。
The study of the relationship between inflammation and heart failure is the focus of the field of cardiology.
目的；系统地回顾罗格列酮长期治疗对心血管的危险，包括心肌梗塞，心力衰竭，心血管病死亡率。
OBJECTIVE: To systematically review the long-term cardiovascular risks of rosiglitazone, including myocardial infarction, heart failure, and cardiovascular mortality.
充血性心力衰竭(C HF)是最常见的心血管病死亡原因之一。
Congestive heart failure (CHF) is one of the main causes of death from cardiac diseases.
目前广泛应用于治疗冠心病、肺心病、心力衰竭、病毒性心肌炎等心血管疾病。
It can be used for curing coronary disease, pulmonary heart disease, heart failure and viral myocarditis.
我们检测血浆瘦素水平与老年人充血性心力衰竭和心血管疾病患病风险和死亡率的高低有关这一假说。
We tested the hypothesis that leptin levels are associated with greater risk of CHF, CVD, and mortality in elderly individuals.
随访至术后6个月，观察两组主要心血管事件发生率（死亡、非致死性心梗、靶血管血运重建术、新发心功能衰竭）。
Main Adverse Cardiac Events: At 6 month follow-up, there didn't exist statistics difference in the incidence of death, non-fatal MI and TVR between two groups.
随访至术后6个月，观察两组主要心血管事件发生率（死亡、非致死性心梗、靶血管血运重建术、新发心功能衰竭）。
Main Adverse Cardiac Events: At 6 month follow-up, there didn't exist statistics difference in the incidence of death, non-fatal MI and TVR between two groups.
应用推荐